Clinical Trial Update: A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intracoronary stenting with or without abciximab to conventional angioplasty with abciximab in patients with coronary artery disease; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Angioplasty, Transluminal, Percutaneous Coronary | Phase 3 | Status: COMPLETED